Erythromelalgia successfully treated with low-dose gabapentin in a pediatric patient

Celine H Phong; Suzanne W Birmingham; Nathan W Rojek

doi:10.1177/2050313X221136768

Erythromelalgia successfully treated with low-dose gabapentin in a pediatric patient

SAGE Open Med Case Rep. 2022 Nov 14:10:2050313X221136768. doi: 10.1177/2050313X221136768. eCollection 2022.

Authors

Celine H Phong¹, Suzanne W Birmingham², Nathan W Rojek²

Affiliations

¹ School of Medicine, University of California, Irvine, CA, USA.
² Department of Dermatology, University of California, Irvine, CA, USA.

Abstract

Primary erythromelalgia, while uncommon, may significantly decrease the quality of life of those affected. While many patients with erythromelalgia require systemic therapy, there is no standard of care for this condition. Herein, we report a 7-year-old girl who experienced resolution of erythromelalgia symptoms with no adverse effects after treatment with low-dose gabapentin. We also discuss the safety and efficacy of low-dose gabapentin in children for treatment of pain.

Keywords: Erythromelalgia; erythermelalgia; neurontin; oral gabapentin; pain; pediatrics; primary erythromelalgia.

Publication types

Case Reports